No services found
No Products found
Developing antibodies against cancer targets? Discover the world’s first Human Cancer Phage Display Library
You work on a new target and no ELISA kit exists? You try to detect a target at very low concentration? It’s time to try our ELISA assay development service! With 1500+ antibodies produced, our unique expertise in antibody development and ELISA design is your best guarantee to get the most specific and sensitive ELISA assay!
An ideal example of the insights you can expect from this type of report
This comprehensive report includes:
Download the Data Report
Satisfaction guaranteed!
We guarantee that your ELISA assay will work following your requirements.
From small molecule to large protein
Our unrivalled know-how in antibody generation is our best tool to offer highly sensitive and specific ELISA assays
ELISA assay design experts
You get access to our unique expertise and technical capabilities in ELISA assay design for various applications.
PhD account managers
As the development of an ELISA assay is highly technical, we put PhD account managers at your disposal to guide you along the process
Antibody production leader
Benefit from the expertise of an antibody production leader and from all the latest antibody generation technologies: hybridoma development, phage display…
One-stop solution
From gene synthesis to ELISA kit development
We guarantee to deliver the antigen and a pair of antibodies that detect your target in your samples. At the end of the process, we provide you with samples of the antibodies and antigen to verify the conformity towards the initial specifications. If you are satisfied, you pay the total amount. Otherwise, we charge 50% of the total cost only if we have been able to develop a sandwich ELISA against the antigen. Therefore, we take on the major part of the risk of your R&D or diagnostic project.
Having helped a large number of corporations, laboratories and individual researchers with our custom ELISA assay development services, we have managed to establish and fine-tune a thorough custom assay development procedure that takes into account every aspect of your research to deliver adaptive assay solutions for research, CE or IVD purposes. Here’s the blueprint of our custom assay services:
Once we have determined that existing ELISA kits, ELISA sandwiches or antibody pairs aren’t sufficient to meet your requirements (specificity, sensitivity, cross-reactivity, etc.), we design a fully customized strategy for assay development, in consultation with you. This is a very important step that determines the success of the projet. There are many possible strategies to develop an assay that meets specific requirements and every step of the process is critical.
Our custom assay development strategy starts to materialize with double-stranded cDNA synthesis. With enhanced quality controls to guide our system, we guarantee 100% accurate sequencing, with an overall efficiency exceeding 99.9%. We further perfect our gene synthesis protocol with a run of gene mutagenesis to remove any traces of errors. Over the years, we have established a formidable reputation of being among the best service providers when it comes to the successful production of custom reagents starting with accurate gene optimization and synthesis. Gene optimization and construction design are very important to produce at the next step the most suitable antigen.
Precision driven production of recombinant protein chains or peptide with sufficient yield factor to sustain further antibody development is a vital step, as far as custom assay development is concerned. With an extensive expertise in this regard, we ensure that our custom Competitive ELISA, custom Sandwich ELISA or other assay formats’ development processes are built on a solid base of antibodies developed with efficient antigen production of high purity.
Protein/peptide production, depending upon your project requirements and research goals, can also be expressed for sample delivery in best-fitting systems, including E.coli, B.subtilis, yeast, insect cells (baculovirus) and mammalian cells, to diversify downstream procedures in assay development. If need be, our team of scientists will also express recombinant protein or peptide in all these systems in parallel, so as to find the best expression conditions and improve the end-result validity of the antibodies used in the custom assay commissioned by you.
We go about great care while developing primary antibodies from the antigen sample generated in the earlier step. As you must be aware, this is perhaps the most sensitive process in the custom assay development project, and that’s why, we have developed along the years an expertise in monoclonal and polyclonal antibodies that is peerless. Along with the cutting-edge techniques and equipment available in our labs, it’s also noteworthy that all of our animal facilities respect the highest ethical standards.
Generation of Monoclonal Antibodies
Upon successful production of desired primary antibodies, we set in motion our analytical services. Prior to conjugation, we offer three advanced, label-free techniques of antibody affinity measurement to gauge the levels of biomolecular interactions.
The next step in our custom assay development services is the conjugation of antibodies. Thanks to the purity of antibodies produced in the earlier step, we can guarantee that the end-result of antibody conjugation will contain no stray protein chains or amine groups that can have a bearing on the conjugation process. Using the latest advanced techniques with a choice of multiple labelling methods, we leave no stone unturned to successfully accomplish this vital step towards accurate assay development.
Working in symmetry with primary antibody development processes (see step 5), we determine and develop the best matched pairs of antibodies (coating antibodies and detection antibodies) for the custom sandwich ELISA assay. We carry out at least 90 pair matching tests to make sure that the most suitable antibody pair is selected. The accuracy of a Sandwich ELISA kit will wholly be a direct function of successful matching, and hence, it’s important to go with an experienced custom assay development supplier like ProteoGenix who masters all the process from gene synthesis to kit pilot productions.
Based on the uniqueness of the target antigen and the desired antibody sensitivity, we proceed to develop a fully optimized ELISA protocol (Sandwich ELISA, Competitive ELISA or other format). The development of Sandwich ELISA or Competitive ELISA protocol drives the custom assay development project towards completion. The purpose of this step is usually to optimize the signal, sensitivity and reproducibility while reducing the noise/background to the minimum.
Thus developed custom Sandwich ELISA or Competitive ELISA assay protocol is then subjected to multiple process adjustments in order to optimize the following against the antigen:
Towards the conclusion of the custom ELISA development process, the developed custom assay is validated on the assigned biological samples to ensure that the detection of endogenous protein(s) in question is successful. Assay validation also provides veritable assurance that the target detection is consistent with recombinant protein/peptide developed.
Once the custom assay is fully developed and validated, we seek our customers’ approval to go ahead with the pilot production of kits. Keeping in line with our thorough approach regarding all procedures that custom assay development consists of; we deliver all the necessary reagents in fully developed and optimized states to facilitate the use of the custom assay in your laboratory. We eventually deliver dozens or hundreds of ready to use kits including pre-coated plates and all necessary reagents to perform the tests.
“We are thrilled with the success we’ve achieved through our collaboration with ProteoGenix in developing monoclonal antibodies targeting our protein. The antibodies they produced were not only highly selective but also demonstrated exceptional affinity for our target, significantly advancing our research. ProteoGenix impressed us with their efficiency and speed throughout the process. Their commitment to providing excellent customer service made our experience even better, as they were always available to address our questions and concerns. We highly recommend ProteoGenix to anyone in need of high-quality antibody development.”
Verónica Alcolea, Product Development Manager, Telum Therapeutics, Spain
There are many factors to consider when choosing the most appropriate ELISA technique for your project. Here are some of the elements you should consider before making the decision:
As a leader in antibody production, ProteoGenix is able to develop all types of ELISA assays, whatever your requirements. If you would like to know more about our ELISA assay development service or if you have any doubt about the best format to use, feel free contact our PhD account managers.
In direct ELISA, the protein antigen is non-specifically adsorbed to the well and washed up to suppress the amount of non-adsorbed antigen. Then, the antigen is directly detected by a labeled antibody.
There are two main advantages of using direct ELISA compared to other ELISA techniques:
Its simple process as it requires less steps than other ELISA techniques
It prevents the secondary antibody cross-reactivity
However, there are also some disadvantages such as:
The unspecific protein immobilization which leads to the coating of the plate with all the proteins of the sample and therefore to higher background noise
This technique requires a labeled primary antibody inducing a necessary conjugation for each target antigen
In indirect ELISA, the protein is non-specifically adsorbed to the well. This technique is called indirect ELISA because the antigen is detected indirectly through the use of a secondary antibody. Thus, the detection occurs in two steps. In the first one, an unlabeled antibody specific of the antigen is added. Then, a secondary antibody (polyclonal or monoclonal) detecting the primary antibody is added.
The main advantages of using indirect ELISA are:
The possibility to use several primary antibodies with a unique secondary antibody
The high sensitivity thanks to the high labeled secondary antibody density achievable leading to signal amplification (more than only one per antigen)
However, indirect ELISA also suffers from some drawbacks:
The presence of a secondary antibody that could lead to cross-reactivity
The longer process as compared to direct ELISA
Sandwich ELISA differs from direct and indirect ELISA as a capture antibody is bound to the plate instead of the antigen. Sandwich ELISA is based on the development of matched antibody pairs. A matched antibody pair is composed of two antibodies: the first one is used as a capture reagent and is directly coated to the plate, the second one is used as detection reagent. It is important that each of these antibodies detect different epitopes of the same antigen. Both direct and indirect detection can be used in a sandwich ELISA. Direct sandwich ELISA involves a labeled primary antibody as detection reagent whereas indirect ELISA uses a labeled secondary antibody detecting the primary antibody.
Sandwich ELISA offers several advantages over the other ELISA techniques:
Thanks to the use of two primary antibodies, each specific of a different epitope of the same antigen, sandwich ELISA is highly specific.
Sandwich ELISA even demonstrates a higher sensitivity than indirect ELISA due to the presence of a capture antibody only grabbing the antigen of interest. All the unwanted entities are washed up allowing for an accurate and sensitive detection of the antigen of interest.
However, sandwich ELISA requires two antibodies targeting a different epitope of a same antigen. Thus, a custom antibody development might be necessary.
Competitive ELISA is a complex technique which is particularly suitable for small antigens. Competitive ELISA is mainly used to measure the concentration of an antigen (or antibody) in a sample. The principle is to detect interferences in a signal output induced by the competition between the sample antigen (or antibody) and a labeled binding reference (antigen or antibody). As the signal is induced by the labeled reference, the rule is the following: “the weaker the signal, the higher the concentration of the analyte in the sample”.
Competitive ELISA can be based on direct, indirect or sandwich ELISA. Therefore, the advantages and drawbacks are related to the selected technique.
With the best-in-class equipment, highly qualified and experienced scientists on board and a reputation that precedes our name, we, at ProteoGenix, are fully committed to providing nothing but the very best custom assay development services to you – all at a fair price, and with extensive guarantees, end-to-end quality control and quick turnaround times.
One step in the right direction saves you a hundred in the wrong one. So, let us bear the responsibility of developing and validating custom assays for you, so that you can drive your research further – much, much further!
Click ‘Contact US’ on your right to get in touch with us, ask us questions or request a quote. Keep reading on to learn more about how our custom assay development services can add that much-needed time, effort & cost effectiveness to your project.
Having developed hundreds of assays since 2003, ProteoGenix has indeed established emphatic expertise in a variety of fields. Here’s where we stand taller than our competitors when it comes to custom assay development::
At ProteoGenix, we have on board a team of eminent scientists with illustrious academic, research and industrial backgrounds. Having at helm such a wealth of experience, we possess incomparable expertise in molecular biology, protein engineering, antibody & immunology and peptide synthesis.
While ProteoGenix offers a number of multipurpose custom ELISA services including Direct ELISA assay services, Indirect ELISA assay services, Sandwich ELISA assay services and Competitive ELISA assay services, custom assay development often emerges as the best solution when you require validation / production kit for projects project involving very specific targets or markers. We work with automated Sandwich ELISA and Competitive ELISA techniques to develop the best-fitting assay solutions for you. According to the requested sensitivity and technology, we can develop colorimetric assays as well as fluorescent assay.. Our services include assay development for drug discovery but also for diagnostic or research purposes.
With a long-standing commitment to the academic and industrial research community all over the world, we, at ProteoGenix, know what it takes to synergistically complement the countless hours you put into your research. Keeping the requirements of researchers in mind, we have developed a comprehensive custom assay development system that will take the pressure of validation and repetition of results off your shoulders.
A basic yardstick to decide whether your project requires a custom assay developed or a standard, off-the-shelf assay kit will do just fine is to assess:
If you can’t decide, feel free to get in touch with us and we will be more than happy to advise.
Here are some of the most common areas of application in which custom assay development comes to the fore:
The best way to demonstrate our expertise in custom assay development is to share a representative case study of a biomarker assay we developed.
The aim of this project was to develop and optimize a biomarker assay to detect high levels of a biomarker specific to the early stage(s) of prostate cancer previously identified. The sample set of serum donors for validation consisted of healthy individuals, individuals with breast cancer and target individuals, i.e. individuals with prostate cancer.
Standard OHS screening protocol was deployed to identify the regulators of a common protein target of anticancer drugs. The following figure (FIGURE 1) illustrates the generic working principle behind OHS screening.
Principle of OHS system
In vivo identification of DNA-Binding protein thanks to fusion with GAL4-AD and activation of a reporter gene
The steps detailed below were followed to develop a Sandwich ELISA protocol for the biomarker discovered via OHS screening in the preliminary stage of the custom assay development project.
As described in the step 4 earlier, an antibody matching experiment resulted in a set of highly reliable data points that were tabulated, and graphically and empirically analysed to determine the most suitable pair match.
The following graph (GRAPH 1) details the matching experiment results derived from matching various antibody pairs.
GRAPH 1: DETERMINATION OF THE BEST PAIR FOR SANDWICH ELISA
As can be clearly noticed, Detection Antibody 4B and Detection Antibody 5B exhibit remarkably good pairing with Coating Antibody 17. Among these two contenders, the pair of Detection Antibody 5B and Coating Antibody 17 was noticed to provide consistently better pairing. Thus, empirical and experimental analysis of over 90 pairs allowed us to zero in on the best pair match.
Once the best pair of antibodies is determined, using a Sandwich ELISA approach, a specifically optimized detection protocol was created. This involved the choice and usage of appropriate blocking buffers, along with suitable incubation periods, antibody dilutions and other parameters.
The following graph (GRAPH 2) plots the concentration values against the associated OD, giving us a highly reliable and accurate empirical curve that can be used in the future for extrapolation needs as a part of the complete Sandwich ELISA protocol for this biomarker assay.
GRAPH 2: DETECTION THRESHOLD DETERMINATION IN BLOOD SAMPLES
Conclusion: this optimized Sandwich ELISA protocol allows detecting the biomarker at a concentration ≤0.2 ng/ml in patient blood samples.
The evaluation of the custom ELISA Sandwich protocol was carried out using blood samples from healthy donors, breast cancer patients and prostate cancer patients. The optimized ELISA protocol was used to assay biomarker levels in samples compared to PSA levels.
The following graph (GRAPH 3) illustrates the high levels of prostate specific biomarker in prostate cancer patients, as detected by the custom Sandwich ELISA protocol developed at ProteoGenix, enabling the categorical discrimination between non-prostate cancer patients (healthy donors and breast cancer patients) and prostate cancer patients. This discrimination was much clearer and more conclusive than when assaying PSA biomarker.
GRAPH 3: DETERMINATION OF PROSTATE-SPECIFIC ANTIGEN LEVEL IN BLOOD SAMPLES OF HEALTHY AND CANCER PATIENTS (SANDWICH ELISA)
A huge increase of Prostate-specific biomarker level is detected in prostate cancer patients
This case study represents a lot more than just facts, figures and data. Such advancement and ability to customize the assay development process – otherwise a long, tedious and meticulous task – to this degree is a great asset to have at researchers’ disposal. Custom assay development not only provides solutions tailored for your projects, but it also saves precious time, energy and other resources that you would otherwise spend on trying to make standardized assays work.
ELISA sandwich is usually a method to assay a protein (in blue in the chart below) in different kinds of samples such as serum samples using a pair of antibodies. The capture antibody (in green below) is quoted to the plastic of 96 well plates whereas the detection antibody (in red in the chart below) will allow a detection signal to be released. In an ELISA sandwich, the detection antibody can be directly conjugated to biotin, HRP or AP (in yellow in the chart below) but it is also possible to use a conjugated secondary antibody to detect it if the coating antibody is from a different host species.
Got a question or need a quote? Message us and we’ll get back to you 48 hours or less.
Your cart is currently empty.